Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has John Wilding's publication output changed over time?
ScholarIQpublication output · 1996–2025
Output grew0% over the shown period — from 1 works in 1996 to 1 in 2025.
1
1
1
2
1
3
1
1
1
199620122015201620172018202120222025
What are the most-cited papers on John Wilding?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
New England Journal of Medicine. 20186,387 CitationsOPEN ACCESS
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna, Melanie J. Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara McGowan, Julio Rosenstock, Marie Thi Dao Tran, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F. Kushner
New England Journal of Medicine. 20214,748 CitationsOPEN ACCESS
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
The Lancet. 20182,848 Citations
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka, Frank L. Greenway, Alfredo Halpern, Michel Krempf, David C.W. Lau, Carel W. le Roux, Rafael Violante Ortíz, Christine B. Jensen, John Wilding
New England Journal of Medicine. 20152,641 CitationsOPEN ACCESS
A role for glucagon-like peptide-1 in the central regulation of feeding
Mandy D. Turton, Donal O’Shea, I. Gunn, S. A. Beak, C. M. B. Edwards, Karim Meeran, S. J. Choi, Gillian M. Taylor, M Heath, Philip Lambert, John Wilding, David M. Smith, Mohammad A. Ghatei, J. Herbert, S.R. Bloom
Nature. 19961,954 Citations
Related on ScholarIQ
University of Liverpool
Institution
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Paper
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Paper
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Paper
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Paper
A role for glucagon-like peptide-1 in the central regulation of feeding
Paper